Intravenous administration of paclitaxel in Sprague-Dawley rats: What is a safe dose?

Biopharmaceutics and Drug Disposition

Volumn 27, Issue 4, 2006, Pages 191-196

  Shord, Stacy S ^a   Camp, Joseph R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Intravenous; Paclitaxel; Pharmacokinetic; Rats

Indexed keywords

PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG SAFETY; DYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MORBIDITY; NONHUMAN; RAT; RAT STRAIN;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; INJECTIONS, INTRAVENOUS; MALE; PACLITAXEL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33744483088     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.503     Document Type: Article

References (21)

1. Ghersi D, Wilcken N, Simes J, Donoghue E. Taxane containing regimens for metastatic breast cancer. Cochrane Database Syst Rev 2003; (3): CD003366.
2. Guastalla JP, 3rd, Dieras V. The taxanes: toxicity and quality of life considerations in advanced ovarian cancer. Br J Cancer 2003; 89(Suppl 3): S16-S22.
3. Rigas JR. Taxane-platinum combinations in advanced non-small cell lung cancer: a review. Oncologist 2004; 9(Suppl 2): 16-23.
4. Simpson D, Plosker GL. Paclitaxel: as adjuvant or neoadjuvant therapy in early breast cancer. Drugs 2004; 64: 1839-1847.
5. Pazdur R, Kudelka AP, Kavanagh JJ, et al. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). Cancer Treat Rev 1993; 19: 351-386.
6. Kearns CM. Pharmacokinetics of the taxanes. Pharmacotherapy 1997; 17(5 Pt 2): 105S-109S.
7. Sparreboom A, van Tellingen O, Nooijen WJ, Beijnen JH. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. Cancer Res 1996; 56: 2112-2115.
8. Jamis-Dow CA, Klecker RW, Katki AG, Collins JM. Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences. Cancer Chemother Pharmacol 1995; 36: 107-114.
9. Sparreboom A, van Zuylen L, Brouwer E, et al. Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications. Cancer Res 1999; 59: 1454-1457.
10. Sparreboom A, van Tellingen O, Nooijen WJ, Beijnen JH. Preclinical pharmacokinetics of paclitaxel and docetaxel. Anticancer Drugs 1998; 9: 1-17.
11. Gianni L, Kearns CM, Giani A, et al. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. J Clin Oncol 1995; 13: 180-190.
12. Li C, Yu D, Inoue T, et al. Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug. Anticancer Drugs 1996; 7: 642-648.
13. Tarr BD, Sambandan TG, Yalkowsky SH. A new parenteral emulsion for the administration of taxol. Pharm Res 1987; 4: 162-165.
14. Alkan-Onyuksel H, Ramakrishnan S, Chai HB, Pezzuto JM. A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res 1994; 11: 206-212.
15. Sharma A, Mayhew E, Bolcsak L, et al. Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer 1997; 71: 103-107.
16. Burt HM, Jackson JK, Bains SK, et al. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). Cancer Lett 1995; 88: 73-79.
17. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 1975; 43: 245-254.
18. Jiko M, Yano I, Okuda M, Inui K. Altered pharmacokinetics of paclitaxel in experimental hepatic or renal failure. Pharm Res 2005; 22: 228-234.
19. Chen H, Zhang Z, McNulty C, et al. A high-throughput combinatorial approach for the discovery of a cremophor EL-free paclitaxel formulation. Pharm Res 2003; 20: 1302-1308.
20. Wilson DB, Beck TM, Gundlach CA. Paclitaxel formulation as a cause of ethanol intoxication. Ann Pharmacother 1997; 31: 873-875.
21. Spear LP, Varlinskaya EI. Adolescence. Alcohol sensitivity, tolerance, and intake. Recent Dev Alcohol 2005; 17: 143-159.